Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 53 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06792552
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +35 more
- Locations
-
- Sarah Cannon Research Institute (SCRI) - Lake Nona Orlando, Florida, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- University Medical Center of New Orleans LSU-LCMC Health Cancer Center New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT07419841
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Nebraska Cancer Specialists Omaha, Nebraska, United States
- START New York Lake Success, New York, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT06661720
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
NCT07647744
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- RenJi Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China
A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
NCT07087158
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- The Cancer Hospital of Fudan University Shanghai, China
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
NCT05176483
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
- Locations
-
- Exelixis Clinical Site #67 Phoenix, Arizona, United States
- Exelixis Clinical Site #1 Tucson, Arizona, United States
- Exelixis Clinical Site #123 Palo Alto, California, United States
- Exelixis Clinical Site #59 Santa Barbara, California, United States
NCT07657325
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Changyi Quan Tianjin, Tianjin Municipality, China
NCT07038733
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Yale University New Haven, Connecticut, United States
NCT06722807
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Florida Gainesville, Florida, United States
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Cleveland Clinic Florida Weston, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Siteman Cancer Center, Washington University St Louis, Missouri, United States
NCT07117227
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
- Locations
-
- Peking University Third Hospital Beijing, Beijing Municipality, China
NCT07402109
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Erasmus MC Rotterdam, South Holland, Netherlands
Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
NCT07197580
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- Westmead Hospital Sydney, New South Wales, Australia
- Wollongong Hospital Wollongong, New South Wales, Australia
- Austin Health Heidelberg, Victoria, Australia
- Melbourne Theranostic Innovation Centre (MTIC) Melbourne N., Victoria, Australia
NCT07461090
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Menoufia Faculty of Medicine Shibīn al Kawm, Shebin Elkom, Egypt
NCT07077161
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- LUMC Leiden, South Holland, Netherlands
NCT07369505
- Conditions
- Adenocarcinoma, Breast Cancer Metastatic, Carcinoma, +40 more
- Locations
-
- SOCRU Adelaide, Australia
NCT07181720
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Thyroid Carcinomas, +43 more
- Locations
-
- The 901 Hospital of Joint Logistics Support Force of People Liberation Army Hefei, Anhui, China
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
NCT07175480
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China Nanjing, Jiangsu, China
NCT07172386
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Tianjin Medical University Second Hospital Tianjin, Tianjin Municipality, China
NCT07172802
- Conditions
- Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +40 more
- Locations
-
- Yonsei University Health System, Severance Hospital Seoul, South Korea
- Asan Medical Center Seoul, South Korea
- Samsung Medical Center Seoul, South Korea